Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients.

Dechao Feng,Li Li,Dengxiong Li,Ruicheng Wu,Weizhen Zhu,Jie Wang,Luxia Ye,Ping Han

European journal of medical research（2023）

引用 0|浏览6

暂无评分

摘要

In this study, we found that P4HB might serve as a prognostic biomarker and predict radiotherapy resistance for PCa patients. Downregulation of P4HB expression could inhibit the cell proliferation of PCa cells.

查看译文

关键词

Prolyl 4-hydroxylase subunit beta, Prostate cancer, Radiotherapy resistance, Cell proliferation, Ferroptosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要